# Commission Regulation (EC) No 1831/2006 of 13 December 2006 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Doramectin (Text with EEA relevance), Division 2.3.1

Extent: E+W+S+N.I.

Avermectins
Not for use in animals from which milk is produced for human consumption.’
Pharmacologically active Substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Doramectin
Doramectin
All mammalian food producing species
40 μg/kg
Muscle
150 μg/kg
Fat
100 μg/kg
Liver
60 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2006/1831/annex/division/2/division/2.3/division/2.3.1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2006-1831/annex/division-2/division-2.3/division-2.3.1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.